Luteinizing hormone

DB14741ApprovedInvestigationalProtein Based TherapiesGonadotropins

Luteinizing hormone: Overview.

Mechanism
Curator reviewed
First approval
Canada, 2000 · United States, 1999
Also known as
Luteinising hormone · Luteinising hormone (human) · Luteinizing gonadotropic hormone · Luteotropic hormone · Pituitary luteinizing hormone
Brand names
  • Menopur

Resolves to

Compound
UNII8XA4VN1LH4CAS9002-67-9
Clinical / RWD
RxNorm6383
Targets
P22888LHCGR

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
57Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
14Marketed productsAcross 6 countries and 5 labellers
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Luteinizing hormone, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In